Asim K. Bej, Ph.D., a professor in the UAB Department of Biology, and his research team have developed a new method to test for Vibrio vulnificus, a bacterium common in oysters and other shellfish that is responsible for more than 95 percent of all seafood-related deaths. Currently, the recommended methods for testing post-harvested shellfish for the bacterial pathogens rely upon DNA detection and are complex and time consuming.
Bej's method, which does rely on the basic principles of current testing practices, is dramatically streamlined and amplifies a targeted gene in an isothermal condition followed by confirmation of the presence of the Vibrio vulnificus by using a disposable colorimetric device. Reports in the most recent edition of the Mississippi-Alabama Sea Grant Consortium Sea Briefs newsletter quote U.S. Food and Drug Administration officials who say Bej's new bacterium testing method is extremely cost effective and could eventually be adopted as an industry standard.
UAB and Southern Research joint venture to unveil first productAIMTech’s ResistX treadmill will make its debut at the American College of Sports Medicine’s annual conference.posted 2 days ago 422 viewsUAB Comprehensive Cancer Center awarded $29 million NCI core grantThe UAB Cancer Center has received a $29 million National Cancer Institute renewal grant and is re-designated as “comprehensive” with an outstanding rating as a leader in advancing cancer research and care.posted 2 days ago 848 viewsFixing cystic fibrosis: In vitro studies show therapeutically robust correction of the most common CF gene mutationCystic fibrosis lung cells were restored to 50 percent of healthy function in work that provides the first evidence that novel therapeutic strategies for human patients can be identified based on yeast studies.posted 3 days ago 1929 viewsResearcher’s lifesaving raceways invention goes internationalUAB engineering professor Dean Sicking’s SAFER Barriers will be installed at the historic Le Mans Race Circuit.posted 9 days ago 1301 viewsS&P raises UAB bond ratings on very strong financial and enterprise profilesIdentifying a stable outlook and UAB’s very strong enterprise and financial profile, S&P Global Ratings has raised its rating on various series of general revenue bonds issued by The University of Alabama System Board of Trustees on behalf of UAB.posted 9 days ago 780 viewsHIV vaccine design should adapt as HIV virus mutatesResearchers from UAB, Emory and Microsoft demonstrate that HIV has evolved to be pre-adapted to the immune response, worsening clinical outcomes in newly infected patients.posted 12 days ago 2469 viewsMore than 10 risk factors identified in readmission of pediatric neurosurgery patientsBig data provides insight into patient readmission after pediatric neurosurgery.posted 11 days ago 2219 viewsRheumatoid arthritis: seeking an answer, cell by cellUAB researchers will use a $1.8 million grant to look at single cells for altered expression of the interferon gamma receptor gene.posted 16 days ago 1994 viewsA focus on homelessness as VA and UAB researchers mark National VA Research WeekVA Research support for UAB clinicians and scientists has been important for six decades.posted 17 days ago 1218 viewsRural children at risk for worse health outcomes, higher health care costsResearchers at UAB look to integrate health care within rural communities to improve care for children.posted 16 days ago 1928 views
After 30 years at UAB, VP Marchase announces plans to retireLongtime VP for Research and Economic Development Richard B. Marchase, Ph.D., plans to retire at the end of 2016. During his tenure, UAB annual research expenditures grew from $331 million to $510 million.posted 18 days ago 2336 viewsResearchers find potential breakthrough in binge-eating disorder treatmentA treatment used for depression, Parkinson’s disease and autism shows promise to alleviate obesity in binge-eating disorder patients.posted 19 days ago 3275 viewsUAB Hospital recognized for decreasing inappropriate use of antibioticsAntibiotic use in acute and long-term care facilities is a focus of UAB’s antibiotic stewardship program.posted 22 days ago 1994 viewsTen-year-old finds relief from rare eyelash growthDaniel Deligio, O.D., treats a rare disease and provides successful treatment plan for Sam Peppers.posted 23 days ago 2026 viewsParkinson’s disease pathogenesis is reduced in a rat model using a cell-signaling inhibitor drugResults show that JAK/STAT pathway inhibitors may be a new class of therapeutic treatments for patients with Parkinson’s disease. Acting by reducing inflammation, they prevent neurodegeneration in animal models and may be an important new approach to slow progression of the disease.posted 25 days ago 2403 viewsUAB driving simulator lab has national debut live on TODAYCutting-edge technology and research brings national attention to UAB.posted 29 days ago 3339 viewsStudy shows how different people respond to aspirin — an important cardioprotective drugUnderstanding how people respond to aspirin is key in terms of knowing who will benefit from it.posted a while back 1465 viewsDepartment of Ophthalmology to host 2016 Clinical and Research SymposiumThe University of Alabama at Birmingham School of Medicine and Department of Ophthalmology will host the 2016 Annual Clinical and Research Symposium on May 13-14 at the Westin Birmingham.posted a while back 753 viewsStudy to test ways to improve cognitive functioning of older adults with HIVUAB School of Nursing Professor David Vance, Ph.D., received a five-year, $2.86 million R01 grant to test ways of improving cognitive function in older adults with HIV.posted a while back 1226 viewsFirst-of-its-kind driving simulator lab at UAB powered by donation from Honda Manufacturing of Alabama and ALDOTThe facility will enable new distracted-driving research, addressing a major public health issue that is a leading cause of highway and traffic-related injuries and death.posted a while back 3235 views